EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Antithrombotic therapy in the management of hospitalised patients with COVID-19

Ioannis Koulas, Mark Goldin, Sam Schulman, Alex C Spyropoulos

British Journal of Hospital Medicine · 2023

DOI: 10.12968/hmed.2022.0519 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, 2023. Verfasst von Ioannis Koulas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA. Hauptthemen laut MEDLINE: COVID-19, Venous Thromboembolism, Thrombosis. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hospitalised patients with coronavirus disease 2019 (COVID-19) are at a significantly higher risk of having thromboembolic events while in hospital and in the immediate post-hospital discharge period. Based on early data from observational studies, multiple high quality randomised controlled trials have been conducted worldwide to evaluate optimal thromboprophylaxis regimens to reduce thromboembolism and other COVID-19-related adverse outcomes in hospitalised patients. The International Society on Thrombosis and Haemostasis has published evidence-based guideline recommendations using established methodology for the management of antithrombotic therapy of COVID-19 patients, both in-hospital and in the immediate post-hospital discharge period. A good clinical practice statement supplemented these guidelines based on topics for which there was no or limited high-quality evidence. This review summarises the main recommendations of these documents to serve as a quick access tool for hospital doctors to use in their everyday practice when treating COVID-19 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Venous ThromboembolismThrombosisHumansAnticoagulantsFibrinolytic Agents

Stichwörter der Autor:innen

AnticoagulantsAntiplateletsArterial thromboembolismCoronavirus disease 2019HospitalisationISTH guidelinesVenous thromboembolism

Substanzen

AnticoagulantsFibrinolytic Agents

Autor:innen und Institutionen

  • Institute of Health System Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA.
  • Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
  • Department of Medicine, Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada.
  • Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, NY, USA.

Zitieren

APA

Koulas, I., Goldin, M., Schulman, S., & Spyropoulos, A. C. (2023). Antithrombotic therapy in the management of hospitalised patients with COVID-19. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2022.0519

Vancouver

Koulas I, Goldin M, Schulman S, Spyropoulos AC. Antithrombotic therapy in the management of hospitalised patients with COVID-19. British Journal of Hospital Medicine. 2023. doi:10.12968/hmed.2022.0519

BibTeX
@article{Koulas2023,
  author = {Koulas, Ioannis and Goldin, Mark and Schulman, Sam and Spyropoulos, Alex C},
  title = {Antithrombotic therapy in the management of hospitalised patients with COVID-19},
  journal = {British Journal of Hospital Medicine},
  year = {2023},
  doi = {10.12968/hmed.2022.0519}
}
Kostenlos starten →